It was great to speak with Farhad Hafezi (ELZA Institute, Zurich, Switzerland) about the recent advances that have made an epithelium-on corneal cross-linking procedure possible.
Question
- Why has it taken so long to develop an effective epithelium-on procedure (00:13)
Speaker Disclosure: Farhad Hafezi holds patents and applications for corneal apparatus used for CXL, chromophore for CXL application; and is a shareholder and investor for EMAGine AG.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.
Filmed in coverage of ESCRS 2021.
